How hospice became big business. A new investigation in The New Yorker reveals an industry that at times puts profits before patients.
Reports of antibiotic resistant super-bugs have prompted new efforts to reduce infection rates in hospitals, locker rooms, and schools. An update on the health threat posed by a common but potentially virulent staph bacteria
- Dr. Donald Poretz President, Infectious Diseases Society of America, clinical professor of medicine at Georgetown University School of Medicine, and in private practice of infectious disease on Fairfax, Virginia
- Dr. Stuart Levy Co-Founder of Paratek Pharmaceuticals, professor, Tufts University School of Medicine
- Dr. Carlene Muto Medical director of infection control,University of Pittsburgh Medical Center
- Dr. John Jernigan Deputy chief of prevention and response in the division of healthcare quality promotion, Centers for Disease Control and Prevention
Most Recent Shows
Pulitzer Prize-winning biographer Jon Meacham on the evolution of Abraham Lincoln's moral principles and political leadership -- and what the era of Lincoln can teach us about the state of our democracy today.
What troubles at Twitter say about the state of social media -- and why one tech watcher argues this could transform the industry in positive ways.
Political analyst Norman Ornstein on control of Congress, the red wave that wasn't, and other lessons from the midterm elections.